Saleh Saeed Al Jathnan Al Qahtani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Saleh Saeed Al Jathnan Al Qahtani has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Aalaa Saleh
Faculty of medicine Lebanese University Beirut Lebanon
1 shared publication - Abdulaziz Abdulmalik Althubyani
College of Medicine and Surgery, Taif University, Taif, Saudi Arabia
1 shared publication Abdullah Saleh Mohammed Alyami
1 shared publication- Abdulmalik Abdulelah Bin Kassim
College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia
1 shared publication - Abdulrahman Alzmmam
College of Medicine, Qassim University, Qassim, Saudi Arabia
1 shared publication - Abdulrahman Mohammed M Al Yassain1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (42) , e51132
Nasopharyngeal carcinoma burden in the United States and worldwide, 1990 to 2023
Nasopharyngeal carcinoma (NPC) is a rare but geographically concentrated malignancy. Long-term comparative analyses of NPC trends between the United States and global populations, particularly by sex, are limited. Using Global Burden of Disease 2023 data, we analyzed temporal trends in NPC incidence, prevalence, and mortality from 1990 to 2023 in the United States and worldwide. Age-standardized rates per 100,000 population were calculated. Joinpoint regression estimated annual percent changes (APCs) and average annual percent change (AAPC) with 95% confidence intervals. Pairwise comparisons assessed differences between United States and global trends. Mortality forecasts through 2050 were generated using the established Global Burden of Disease forecasting framework. From 1990 to 2023, US age-standardized mortality declined by 44%, from 0.34 to 0.19 per 100,000 (AAPC: –1.70), while global mortality decreased from 1.46 to 0.83 (AAPC: –1.70). Global mortality increased between 2020 and 2023 (APC: 2.06), unlike the US decline. The incidence rate declined in the United States over the study period (AAPC: –1.03), while remaining largely stable globally. However, global incidence increased between 2020 and 2023 (APC: 3.86). Similarly, prevalence decreased in the United States (AAPC: –0.81) while showing a rising trend worldwide (AAPC: 0.74). Males consistently exhibited higher rates across all measures. Pairwise comparisons showed significant differences between United States and global trends. From 2023 to 2050, global NPC age-standardized mortality rate is projected to increase by 12.05% (0.93, 95% uncertainty interval [UI]: 0.75–1.16), driven by a 21.8% rise in males (1.45, 95% UI: 1.18–1.78), while declining by 11.76% in females (0.45, 95% UI: 0.33–0.63). In the United States, age-standardized mortality rate is projected to increase by 10.5% (0.21, 95% UI: 0.18–0.23), with a 17.9% rise in males (0.33, 95% UI: 0.29–0.37) and an 11.82% decline in females (0.097, 95% UI: 0.08–0.12). US NPC burden has declined steadily, while global patterns show rising prevalence and recent mortality increases. The observed differences in burden and temporal trends underscore the importance of further research into strategies for surveillance, early detection, and prevention in high-risk populations.
- 16 October 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (42) , e51132
Open AccessNasopharyngeal carcinoma burden in the United States and worldwide, 1990 to 2023
Nasopharyngeal carcinoma (NPC) is a rare but geographically concentrated malignancy. Long-term comparative analyses of NPC trends between the United States and global populations, particularly by sex, are limited. Using Global Burden of Disease 2023 data, we analyzed temporal trends in NPC incidence, prevalence, and mortality from 1990 to 2023 in the United States and worldwide. Age-standardized rates per 100,000 population were calculated. Joinpoint regression estimated annual percent changes (APCs) and average annual percent change (AAPC) with 95% confidence intervals. Pairwise comparisons assessed differences between United States and global trends. Mortality forecasts through 2050 were generated using the established Global Burden of Disease forecasting framework. From 1990 to 2023, US age-standardized mortality declined by 44%, from 0.34 to 0.19 per 100,000 (AAPC: –1.70), while global mortality decreased from 1.46 to 0.83 (AAPC: –1.70). Global mortality increased between 2020 and 2023 (APC: 2.06), unlike the US decline. The incidence rate declined in the United States over the study period (AAPC: –1.03), while remaining largely stable globally. However, global incidence increased between 2020 and 2023 (APC: 3.86). Similarly, prevalence decreased in the United States (AAPC: –0.81) while showing a rising trend worldwide (AAPC: 0.74). Males consistently exhibited higher rates across all measures. Pairwise comparisons showed significant differences between United States and global trends. From 2023 to 2050, global NPC age-standardized mortality rate is projected to increase by 12.05% (0.93, 95% uncertainty interval [UI]: 0.75–1.16), driven by a 21.8% rise in males (1.45, 95% UI: 1.18–1.78), while declining by 11.76% in females (0.45, 95% UI: 0.33–0.63). In the United States, age-standardized mortality rate is projected to increase by 10.5% (0.21, 95% UI: 0.18–0.23), with a 17.9% rise in males (0.33, 95% UI: 0.29–0.37) and an 11.82% decline in females (0.097, 95% UI: 0.08–0.12). US NPC burden has declined steadily, while global patterns show rising prevalence and recent mortality increases. The observed differences in burden and temporal trends underscore the importance of further research into strategies for surveillance, early detection, and prevention in high-risk populations.
- Open Access
- 9 December 2025
- Published by Saudi Medical Horizons Journal in Saudi Medical Horizons Journal
- Vol. 6 (1) , 71-81
The Association Between Inflammatory Bowel Disease (IBD) and Thyroid Disorders: Systematic Review
Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is associated with various extraintestinal manifestations, including thyroid disorders. The relationship between IBD and thyroid dysfunction—such as hypothyroidism, hyperthyroidism, and thyroid cancer—remains unclear, with conflicting evidence on prevalence, risk factors, and underlying mechanisms. This systematic review followed PRISMA guidelines, analyzing studies from PubMed, Web of Science, Scopus, and Embase. Eligible studies included observational and genetic investigations on IBD and thyroid disorders. Data extraction and quality assessment were performed using the Newcastle-Ottawa Scale (NOS) and Cochrane Risk of Bias tools. Thirteen studies were included, revealing significant associations between IBD and thyroid disorders. Increased thyroid cancer risk in UC (SIR=10.34) and CD (SIR=10.45) patients. Reduced hypothyroidism prevalence in UC (OR=0.33) in some cohorts. Shared genetic pathways (e.g., IP-10 cytokine mediation) between IBD and autoimmune thyroid disease. Geographic and demographic variations, with higher malignancy risks in Asian IBD populations. IBD is associated with an elevated risk of thyroid disorders, particularly thyroid cancer, though hypothyroidism risk may vary by IBD subtype and population. Immune-mediated mechanisms, including cytokine dysregulation, likely contribute to these associations. Clinicians should consider thyroid screening in high-risk IBD patients, especially those with long-standing disease or specific demographic risk factors. Further research is needed to clarify causal pathways and the impact of IBD treatments on thyroid function.
- 9 December 2025
- Published by Saudi Medical Horizons Journal in Saudi Medical Horizons Journal
- Vol. 6 (1) , 71-81
Open AccessThe Association Between Inflammatory Bowel Disease (IBD) and Thyroid Disorders: Systematic Review
Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is associated with various extraintestinal manifestations, including thyroid disorders. The relationship between IBD and thyroid dysfunction—such as hypothyroidism, hyperthyroidism, and thyroid cancer—remains unclear, with conflicting evidence on prevalence, risk factors, and underlying mechanisms. This systematic review followed PRISMA guidelines, analyzing studies from PubMed, Web of Science, Scopus, and Embase. Eligible studies included observational and genetic investigations on IBD and thyroid disorders. Data extraction and quality assessment were performed using the Newcastle-Ottawa Scale (NOS) and Cochrane Risk of Bias tools. Thirteen studies were included, revealing significant associations between IBD and thyroid disorders. Increased thyroid cancer risk in UC (SIR=10.34) and CD (SIR=10.45) patients. Reduced hypothyroidism prevalence in UC (OR=0.33) in some cohorts. Shared genetic pathways (e.g., IP-10 cytokine mediation) between IBD and autoimmune thyroid disease. Geographic and demographic variations, with higher malignancy risks in Asian IBD populations. IBD is associated with an elevated risk of thyroid disorders, particularly thyroid cancer, though hypothyroidism risk may vary by IBD subtype and population. Immune-mediated mechanisms, including cytokine dysregulation, likely contribute to these associations. Clinicians should consider thyroid screening in high-risk IBD patients, especially those with long-standing disease or specific demographic risk factors. Further research is needed to clarify causal pathways and the impact of IBD treatments on thyroid function.
- Open Access
- 31 May 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18 (2) , 1235-1245
Assessment of Healthcare Workers' Adherence to Infection Prevention and Control Measures in Najran City, Saudi Arabia, in the Post-COVID-19 Pandemic Era
Infection prevention and control (IPC) standards have a unique role in controlling infection transmission. In Saudi Arabia, every healthcare facility is required to establish an IPC program to identify and reduce the risk of infection acquisition and transmission. This study aimed to estimate adherence to IPC measures after the COVID-19 pandemic among healthcare workers (HCWs) in Najran City, Saudi Arabia. This cross-sectional study was conducted among HCWs in Najran City during the period of May to August 2023. A self-administered questionnaire was given to HCWs consisting of three parts: demographic data, profile of healthcare facility and healthcare professional regarding infection control, and questionnaire to assess the adherence of HCWs regarding infection control measures. The study recruited 580 HCWs, of whom 57.6% were males, and 46.6% were aged between 31 and 40 years. The overall mean adherence score was 103.2±9.71 out of 150 points. Accordingly, 88.4% were classified as having moderate adherence, 10.2% were good, and only 1.4% were classified as having poor adherence. Some of the factors associated with increased adherence to IPC measures, include being female, being a nurse, being a practitioner, working in the hospital emergency department, and having a recognized antimicrobial stewardship program team/unit at a healthcare facility. There was satisfactory adherence among HCWs regarding infection prevention and control measures. Being a female, a nurse, a practitioner, working in a hospital emergency department, being a staff of a non-MOH (Ministry of Health) hospital, and having a recognized antimicrobial stewardship program team/unit were identified as significant predictors of increased adherence. IPC measures can be optimized by setting up institutional IPC teams, necessary PPE, and periodic provision of IPC training.
- 31 May 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18 (2) , 1235-1245
Open AccessAssessment of Healthcare Workers' Adherence to Infection Prevention and Control Measures in Najran City, Saudi Arabia, in the Post-COVID-19 Pandemic Era
Infection prevention and control (IPC) standards have a unique role in controlling infection transmission. In Saudi Arabia, every healthcare facility is required to establish an IPC program to identify and reduce the risk of infection acquisition and transmission. This study aimed to estimate adherence to IPC measures after the COVID-19 pandemic among healthcare workers (HCWs) in Najran City, Saudi Arabia. This cross-sectional study was conducted among HCWs in Najran City during the period of May to August 2023. A self-administered questionnaire was given to HCWs consisting of three parts: demographic data, profile of healthcare facility and healthcare professional regarding infection control, and questionnaire to assess the adherence of HCWs regarding infection control measures. The study recruited 580 HCWs, of whom 57.6% were males, and 46.6% were aged between 31 and 40 years. The overall mean adherence score was 103.2±9.71 out of 150 points. Accordingly, 88.4% were classified as having moderate adherence, 10.2% were good, and only 1.4% were classified as having poor adherence. Some of the factors associated with increased adherence to IPC measures, include being female, being a nurse, being a practitioner, working in the hospital emergency department, and having a recognized antimicrobial stewardship program team/unit at a healthcare facility. There was satisfactory adherence among HCWs regarding infection prevention and control measures. Being a female, a nurse, a practitioner, working in a hospital emergency department, being a staff of a non-MOH (Ministry of Health) hospital, and having a recognized antimicrobial stewardship program team/unit were identified as significant predictors of increased adherence. IPC measures can be optimized by setting up institutional IPC teams, necessary PPE, and periodic provision of IPC training.